Search Results for "Outcomes-based%20contracting"

Steep increases in prices and spending on prescription drugs in the United States have triggered public outrage and questions about their value.

Pharmaceutical manufacturers push for adoption of outcomes-based contracting as a means of achieving a value-based price, but such contracts are ill-suited to do so.

Drug Pricing Lab op-ed in STAT News discusses indication-specific pricing of Kymriah.

Katie Thomas and Charles Ornstein examine the costs and benefits of outcomes-based contracting.

What steps are needed to make outcomes-based contracting a value-based approach?